{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:14:26Z","timestamp":1787062466248,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the natural Science Foundation of Zhejiang Provincial in China","award":["LQ24H180011"],"award-info":[{"award-number":["LQ24H180011"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["8217082371"],"award-info":[{"award-number":["8217082371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03440-9","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:13:39Z","timestamp":1749082419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tumor-microenvironment responsive nanomodulator for near infrared photothermal immunotherapy of hepatocellular carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Fei","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"3440_CR1","doi-asserted-by":"publisher","first-page":"122481","DOI":"10.1016\/j.biomaterials.2024.122481","volume":"306","author":"X Pan","year":"2024","unstructured":"Pan X, Ni S, Hu K. Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma. Biomaterials. 2024;306:122481. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122481.","journal-title":"Biomaterials"},{"key":"3440_CR2","doi-asserted-by":"publisher","first-page":"42473","DOI":"10.1021\/acsami.1c11763","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, Chen J, Liu H, Zhang K, Zeng Q, Yang S, Jiang Z, Zhang X, Chen T, Li D, Shan H. Bi\/se-based nanotherapeutics sensitize CT image-guided stereotactic body radiotherapy through reprogramming the microenvironment of hepatocellular carcinoma. ACS Appl Mater Interfaces. 2021;13:42473\u201385. https:\/\/doi.org\/10.1021\/acsami.1c11763.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3440_CR3","doi-asserted-by":"publisher","first-page":"27597","DOI":"10.1021\/acsnano.4c08690","volume":"18","author":"L Zheng","year":"2024","unstructured":"Zheng L, Ding Y, Fang S, Yang W, Chen J, Ma J, Wang M, Wang J, Zhang F, Guo X, Zhang K, Shu GF, Weng Q, Wu F, Zhao Z, Chen M, Song JJ. Potentiated calcium carbonate with enhanced calcium overload induction and acid neutralization capabilities to boost chemoimmunotherapy against liver cancer. ACS Nano. 2024;18:27597\u2013616. https:\/\/doi.org\/10.1021\/acsnano.4c08690.","journal-title":"ACS Nano"},{"key":"3440_CR4","doi-asserted-by":"publisher","first-page":"122435","DOI":"10.1016\/j.biomaterials.2023.122435","volume":"305","author":"Y Fan","year":"2024","unstructured":"Fan Y, Dai LQ, Shi K, Liu QY, Pan M, Mo D, Deng HZ, Yuan LP, Lu Y, Pan LL, Yang TY, Qian YZ. A facile Boronophenylalanine modified polydopamine dual drug-loaded nanoparticles for enhanced anti-tumor immune response in hepatocellular carcinoma comprehensive treatment. Biomaterials. 2024;305:122435. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122435.","journal-title":"Biomaterials"},{"key":"3440_CR5","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.1038\/s41467\/024\/525005","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu J, Zhao H, Gao T, Huang X, Liu S, Liu M, Mu W, Liang S, Fu S, Yuan S, Yang Q, Gu P, Li N, Ma Q, Liu J, Zhang X, Zhang N, Liu Y. Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours. Nat Commun. 2024;15:8203. https:\/\/doi.org\/10.1038\/s41467\/024\/525005.","journal-title":"Nat Commun"},{"key":"3440_CR6","doi-asserted-by":"publisher","first-page":"e2407189","DOI":"10.1002\/adma.202407189","volume":"36","author":"P Zhang","year":"2024","unstructured":"Zhang P, Wang T, Cui G, Ye R, Wan W, Liu T, Zheng Y, Zhong Z. Systemic multifunctional nanovaccines for potent personalized immunotherapy of acute myeloid leukemia. Adv Mater. 2024;36:e2407189. https:\/\/doi.org\/10.1002\/adma.202407189.","journal-title":"Adv Mater"},{"key":"3440_CR7","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1021\/acsnano.3c11464","volume":"18","author":"H Xiao","year":"2024","unstructured":"Xiao H, Li X, Liang S, Yang S, Han S, Huang J, Shuai X, Ren J. Dual-responsive nanomedicine activates programmed antitumor immunity through targeting lymphatic system. ACS Nano. 2024;18:11070\u201383. https:\/\/doi.org\/10.1021\/acsnano.3c11464.","journal-title":"ACS Nano"},{"key":"3440_CR8","doi-asserted-by":"publisher","first-page":"122433","DOI":"10.1016\/j.biomaterials.2023.122433","volume":"305","author":"M Su","year":"2024","unstructured":"Su M, Wang J, Zhao N, Yu B, Wang Y, Xu FJ. Genetically light-enhanced immunotherapy mediated by a fluorinated reduction-sensitive delivery system. Biomaterials. 2024;305:122433. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122433.","journal-title":"Biomaterials"},{"key":"3440_CR9","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1021\/acsnano.3c13143","volume":"18","author":"Z Yang","year":"2024","unstructured":"Yang Z, Teng Y, Lin M, Peng Y, Du Y, Sun Q, Gao D, Yuan Q, Zhou Y, Yang Y, Li J, Zhou Y, Li X, Qi X. Reinforced Immunogenic Endoplasmic reticulum stress and oxidative stress via an orchestrated nanophotoinducer to boost Cancer photoimmunotherapy. ACS Nano. 2024;18:7267\u201386. https:\/\/doi.org\/10.1021\/acsnano.3c13143.","journal-title":"ACS Nano"},{"key":"3440_CR10","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1021\/acsnano.3c08792","volume":"18","author":"S Meng","year":"2024","unstructured":"Meng S, Du H, Li X, Zheng X, Zhao P, Yuan Z, Huang S, Zhao Y, Dai L. An adjuvant micelle-Based multifunctional nanosystem for tumor immunotherapy by remodeling three types of immunosuppressive cells. ACS Nano. 2024;18:3134\u201350. https:\/\/doi.org\/10.1021\/acsnano.3c08792.","journal-title":"ACS Nano"},{"key":"3440_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.xcrm.2023.101375","volume":"15","author":"H Lv","year":"2024","unstructured":"Lv H, Zong Q, Chen C, Lv G, Xiang W, Xing F, Jiang G, Yan B, Sun X, Ma Y, Wang L, Wu Z, Cui X, Wang H, Yang W. TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer. Nat Commun. 2024;15:6. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101375.","journal-title":"Nat Commun"},{"key":"3440_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s43018.023.006713","volume":"5","author":"F Li","year":"2024","unstructured":"Li F, Liu P, Mi W, Li L, Anderson NM, Lesner NP, Burrows M, Plesset J, Majer A, Wang G, Li J, Zhu L, Keith B, Simon MC. Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 Inhibition in liver cancer. Nat Cancer. 2024;5:131\u201346. https:\/\/doi.org\/10.1038\/s43018.023.006713.","journal-title":"Nat Cancer"},{"key":"3440_CR13","doi-asserted-by":"publisher","first-page":"1153802","DOI":"10.3389\/fendo.2023.1153802","volume":"14","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wang Y, Zhang W, Niu K, Mao X, Feng K, Zhang Y. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment. Front Endocrinol (Lausanne). 2023;14:1153802. https:\/\/doi.org\/10.3389\/fendo.2023.1153802.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3440_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41571\/024\/008680","volume":"21","author":"JM Llovet","year":"2024","unstructured":"Llovet JM, Pinyol R, Yarchoan M, Singal AG, Marron TU, Schwartz M, Pikarsky E, Kudo M, Finn RS. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma. Nat Rev Clin Oncol. 2024;21:294\u2013311. https:\/\/doi.org\/10.1038\/s41571\/024\/008680.","journal-title":"Nat Rev Clin Oncol"},{"key":"3440_CR15","doi-asserted-by":"publisher","first-page":"e2300878","DOI":"10.1002\/advs.202300878","volume":"10","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Wu Z, Chen Y, Liao J, Zhang Q, Wang Q, Duan Y, Gong K, Chen S, Wang L, Fan P, Duan Y, Wang W, Dong Y. Nano ultrasound contrast agent for synergistic chemo-photothermal therapy and enhanced immunotherapy against liver cancer and metastasis. Adv Sci (Weinh). 2023;10:e2300878. https:\/\/doi.org\/10.1002\/advs.202300878.","journal-title":"Adv Sci (Weinh)"},{"key":"3440_CR16","doi-asserted-by":"publisher","first-page":"e2307193","DOI":"10.1002\/adma.202307193","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang Z, You T, Su Q, Deng W, Li J, Hu S, Shi S, Zou Z, Xiao J, Duan X. Laser-activatable in situ vaccine enhances cancer-immunity cycle. Adv Mater. 2023;35:e2307193. https:\/\/doi.org\/10.1002\/adma.202307193.","journal-title":"Adv Mater"},{"key":"3440_CR17","doi-asserted-by":"publisher","first-page":"e2307143","DOI":"10.1002\/advs.202307143","volume":"11","author":"W Wang","year":"2024","unstructured":"Wang W, Gao Y, Xu J, Zou T, Yang B, Hu S, Cheng X, Xia Y, Zheng Q. A NRF2 regulated and the immunosuppressive microenvironment reversed nanoplatform for cholangiocarcinoma photodynamic-gas therapy. Adv Sci (Weinh). 2024;11:e2307143. https:\/\/doi.org\/10.1002\/advs.202307143.","journal-title":"Adv Sci (Weinh)"},{"key":"3440_CR18","doi-asserted-by":"publisher","first-page":"e2308780","DOI":"10.1002\/adma.202308780","volume":"36","author":"S Zeng","year":"2024","unstructured":"Zeng S, Chen J, Gao R, Chen R, Xue Q, Ren Y, Liu L, Tang C, Hu H, Zeng N, Wen S, Zhang H, Liu C, Fang C. NIR-II photoacoustic imaging-guided oxygen delivery and controlled release improves photodynamic therapy for hepatocellular carcinoma. Adv Mater. 2024;36:e2308780. https:\/\/doi.org\/10.1002\/adma.202308780.","journal-title":"Adv Mater"},{"key":"3440_CR19","doi-asserted-by":"publisher","first-page":"e2310298","DOI":"10.1002\/adma.202310298","volume":"36","author":"H Zhang","year":"2024","unstructured":"Zhang H, Cui M, Tang D, Wang B, Liang G, Xu C, Xiao H. Localization of cancer cells for subsequent robust photodynamic therapy by ROS responsive polymeric nanoparticles with anti-mtastasis complexes NAMI-A. Adv Mater. 2024;36:e2310298. https:\/\/doi.org\/10.1002\/adma.202310298.","journal-title":"Adv Mater"},{"key":"3440_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1021\/acs.nanolett.8b03709","volume":"19","author":"H Ding","year":"2019","unstructured":"Ding H, Cai Y, Gao L. Exosome-like nanozyme vesicles for H2O2-responsive catalytic photoacoustic imaging of xenograft nasopharyngeal carcinoma. Nano Lett. 2019;19:203\u20139. https:\/\/doi.org\/10.1021\/acs.nanolett.8b03709.","journal-title":"Nano Lett"},{"key":"3440_CR21","doi-asserted-by":"publisher","first-page":"2005562","DOI":"10.1002\/adma.202005562","volume":"33","author":"JJ Ding","year":"2021","unstructured":"Ding JJ. Self-activatable photo-extracellular vesicle for synergistic trimodal anticancer therapy. Adv Mater. 2021;33:2005562. https:\/\/doi.org\/10.1002\/adma.202005562.","journal-title":"Adv Mater"},{"key":"3440_CR22","doi-asserted-by":"publisher","unstructured":"Zhang Y, Chen L, Fu T. Self-stimulated photodynamic nanoreactor in combination with CXCR4 antagonists for antileukemia therapy. ACS Appl Mater Interfaces. 2024;9. https:\/\/doi.org\/10.1021\/acsami.4c01603.","DOI":"10.1021\/acsami.4c01603"},{"key":"3440_CR23","doi-asserted-by":"publisher","first-page":"17377","DOI":"10.1021\/jacs.3c05052","volume":"145","author":"WT Dou","year":"2023","unstructured":"Dou WT, Qiu P, Shi Y, Zhu L, Guo C, Li N, Zang Y, Liu T, Zhao S, Pan Y, Dong L, Sessler JL, Tan Y, Li J, Wang H, Tian H, He XP. Orthogonally engineered albumin with attenuated macrophage phagocytosis for the targeted visualization and phototherapy of liver cancer. J Am Chem Soc. 2023;145:17377\u201388. https:\/\/doi.org\/10.1021\/jacs.3c05052.","journal-title":"J Am Chem Soc"},{"key":"3440_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.actbio.2021.03.051","volume":"127","author":"H Cai","year":"2021","unstructured":"Cai H, Dai X, Guo X, Zhang L, Cao K, Yan F, Ji B, Liu Y. Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma. Acta Biomater. 2021;127:276\u201386. https:\/\/doi.org\/10.1016\/j.actbio.2021.03.051.","journal-title":"Acta Biomater"},{"key":"3440_CR25","doi-asserted-by":"publisher","unstructured":"Gao X, Bao K, Zhang Y, Liu L, Li Y, Hu C, Zhao Y, Lu W, Wei X. The synergistic effects of multidrug-loaded nanocarriers improve tumor microenvironment responsive chemo-sonodynamic therapy of hepatocellular carcinoma. Adv. Funct. Mater. 2023;33:2215014. https:\/\/doi.org\/10.1002\/adfm.202215014","DOI":"10.1002\/adfm.202215014"},{"key":"3440_CR26","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.7150\/thno.54822","volume":"11","author":"FH Kong","year":"2021","unstructured":"Kong FH, Ye QF, Miao XY, Liu X, Huang SQ, Xiong L, Wen Y, Zhang ZJ. Current status of Sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma. Theranostics. 2021;11:5464\u201390. https:\/\/doi.org\/10.7150\/thno.54822.","journal-title":"Theranostics"},{"key":"3440_CR27","doi-asserted-by":"publisher","unstructured":"Du Z, Mao Y, Zhang P, Hu J, Fu J, You Q, Yin J. TPGS-galactose-modified polydopamine co-delivery nanoparticles of nitric oxide donor and doxorubicin for targeted chemo-photothermal therapy against drug-resistant hepatocellular carcinoma. ACS Appl Mater Interfaces 13:35518\u201332, https:\/\/doi.org\/10.1021\/acsami.1c09610","DOI":"10.1021\/acsami.1c09610"},{"key":"3440_CR28","doi-asserted-by":"publisher","first-page":"eabn2941","DOI":"10.1126\/sciadv.abn2941","volume":"8","author":"Y Guo","year":"2022","unstructured":"Guo Y, Zhang Q, Zhu Q, Gao J, Zhu X, Yu H, Li Y, Zhang C. Copackaging photosensitizer and PD-L1 SiRNA in a nucleic acid nanogel for synergistic cancer photoimmunotherapy. Sci Adv. 2022;8:eabn2941. https:\/\/doi.org\/10.1126\/sciadv.abn2941.","journal-title":"Sci Adv"},{"key":"3440_CR29","doi-asserted-by":"publisher","first-page":"2409661","DOI":"10.1002\/adma.202409661","volume":"6","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu D, Chen W, Tao Y, Li W, Qi J. Microenvironment-activatable probe for precise NIR-II monitoring and synergistic immunotherapy in rheumatoid arthritis. Adv Mater. 2024;6:2409661. https:\/\/doi.org\/10.1002\/adma.202409661.","journal-title":"Adv Mater"},{"key":"3440_CR30","doi-asserted-by":"publisher","unstructured":"Shi X, Wang Y, Qi F, Zhang H, Cao Y, Xu X, Liu W, Li C. Devising biocompatible, NIR-activated helical pyroptosis agents via \u03c0-twisting strategy for promoting antitumor immunity. Small. 2024:182405496. https:\/\/doi.org\/10.1002\/smll.202405496.","DOI":"10.1002\/smll.202405496"},{"key":"3440_CR31","doi-asserted-by":"publisher","first-page":"28104","DOI":"10.1021\/acsnano.4c07558","volume":"18","author":"Y Huang","year":"2024","unstructured":"Huang Y, Zhao H, Zhang Y, Zhao C, Ren J, Qu X. Bioorthogonal regulated metabolic balance for promotion of ferroptosis and mild photothermal therapy. ACS Nano. 2024;18:28104\u201314. https:\/\/doi.org\/10.1021\/acsnano.4c07558.","journal-title":"ACS Nano"},{"key":"3440_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jconrel.2024.09.042","volume":"28","author":"M Mu","year":"2024","unstructured":"Mu M, Chen B, Li H, Fan R, Yang Y, Zhou L, Han B, Zou B, Chen N, Guo G. Augmented the sensitivity of photothermal-ferroptosis therapy in triple-negative breast cancer through mitochondria-targeted nanoreactor. J Control Release. 2024;28:733\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2024.09.042.","journal-title":"J Control Release"},{"key":"3440_CR33","doi-asserted-by":"publisher","first-page":"12933","DOI":"10.1021\/acsnano.4c00833","volume":"18","author":"P Yang","year":"2024","unstructured":"Yang P, Xu Y, Zhi X, Li R, Wang B, Liu R, Dai Z, Qian L. Photodynamically tumor vessel destruction amplified tumor targeting of nanoparticles for efficient chemotherapy. ACS Nano. 2024;18:12933\u201344. https:\/\/doi.org\/10.1021\/acsnano.4c00833.","journal-title":"ACS Nano"},{"key":"3440_CR34","doi-asserted-by":"publisher","first-page":"119760","DOI":"10.1016\/j.biomaterials.2020.119760","volume":"234","author":"S Li","year":"2020","unstructured":"Li S, Saw PE, Lin C, Nie Y, Tao W, Farokhzad OC, Zhang L, Xu X. Redox-responsive polyprodrug nanoparticles for targeted SiRNA delivery and synergistic liver cancer therapy. Biomaterials. 2020;234:119760. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119760.","journal-title":"Biomaterials"},{"key":"3440_CR35","doi-asserted-by":"publisher","first-page":"e2311803","DOI":"10.1002\/adma.202311803","volume":"36","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Li Q, Niu J, Guo E, Zhao C, Zhang J, Liu X, Wang L, Rao L, Chen X, Yang K. Neutrophil membrane-camouflaged polyprodrug nanomedicine for inflammation suppression in ischemic stroke therapy. Adv Mater. 2024;36:e2311803. https:\/\/doi.org\/10.1002\/adma.202311803.","journal-title":"Adv Mater"},{"key":"3440_CR36","doi-asserted-by":"publisher","first-page":"e2308790","DOI":"10.1002\/smll.202308790","volume":"20","author":"W Xiao","year":"2024","unstructured":"Xiao W, Geng R, Bi D, Luo Y, Zhang Z, Gan Q, Liu Y, Zhu J. PH\/H2O2 Cascade-responsive nanoparticles of lipid-like prodrugs through dynamic-covalent and coordination interactions for chemotherapy. Small. 2024;20:e2308790. https:\/\/doi.org\/10.1002\/smll.202308790.","journal-title":"Small"},{"key":"3440_CR37","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1039\/D2CS00889K","volume":"52","author":"Q Fu","year":"2023","unstructured":"Fu Q, Shen S, Sun P, Gu Z, Bai Y, Wang X, Liu Z. Bioorthogonal chemistry for prodrug activation in vivo. Chem Soc Rev. 2023;52:7737\u201372. https:\/\/doi.org\/10.1039\/D2CS00889K.","journal-title":"Chem Soc Rev"},{"key":"3440_CR38","doi-asserted-by":"publisher","first-page":"122365","DOI":"10.1016\/j.biomaterials.2023.122365","volume":"302","author":"H Zhang","year":"2023","unstructured":"Zhang H, Shi C, Han F, Cai L, Ma H, Long S, Sun W, Du J, Fan J, Chen X, Peng X. Synchronized activating therapeutic nano-agent: enhancement and tracing for hypoxia-induced chemotherapy. Biomaterials. 2023;302:122365. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122365.","journal-title":"Biomaterials"},{"key":"3440_CR39","doi-asserted-by":"publisher","first-page":"101106","DOI":"10.1016\/j.nantod.2021.101106","volume":"37","author":"F Kong","year":"2021","unstructured":"Kong F, Bai HY, Liu D, Chen Y, Zhuang LL, Ma M, Wang C, Xu HY, Gu N, Zhang Y. Fe3O4@Pt nanozymes combining with CXCR4 antagonists to synergistically treat acute myeloid leukemia. Nano Today. 2021;37:101106. https:\/\/doi.org\/10.1016\/j.nantod.2021.101106.","journal-title":"Nano Today"},{"key":"3440_CR40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bioactmat","volume":"18","author":"F Kong","year":"2022","unstructured":"Kong F, Bai HY, Gu N, Zhang Y. A biomimetic nanocomposite with enzyme-like activities and CXCR4 antagonism efficiently enhances the therapeutic efficacy of acute myeloid leukemia. Bioactive Mater. 2022;18:526\u201338. https:\/\/doi.org\/10.1016\/j.bioactmat.","journal-title":"Bioactive Mater"},{"key":"3440_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/acsami.4c01603","volume":"17","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen L, Fu T. Self-stimulated photodynamic nanoreactor in combination with CXCR4 antagonists for antileukemia therapy. ACS Appl Mater Interfaces. 2024;17:16. https:\/\/doi.org\/10.1021\/acsami.4c01603.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3440_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41467.023.35828.2","volume":"14","author":"W Gao","year":"2023","unstructured":"Gao W, He J, Chen L, Meng X, Ma Y, Cheng L, Tu K, Gao X, Liu C, Zhang M. Deciphering the catalytic mechanism of superoxide dismutase activity of carbon Dot nanozyme. Nat Commun. 2023;14:160. https:\/\/doi.org\/10.1038\/s41467.023.35828.2.","journal-title":"Nat Commun"},{"key":"3440_CR43","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1021\/acsnano.1c01248","volume":"15","author":"X Meng","year":"2021","unstructured":"Meng X, Li D, Chen L, He H, Wang Q, Hong C, He J, Gao X, Yang Y, Jiang B. High-performance self-cascade pyrite nanozymes for apoptosis\u2013ferroptosis synergistic tumor therapy. ACS Nano. 2021;15:5735\u201351. https:\/\/doi.org\/10.1021\/acsnano.1c01248.","journal-title":"ACS Nano"},{"key":"3440_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.161200","author":"F Kong","year":"2025","unstructured":"Kong F, Dong Y, Hong CY, Wang YG, Xia L. Biomimetic multifunctional nanocomposites for precise catalytic immunotherapy of glioblastoma. Chem Eng J. 2025. https:\/\/doi.org\/10.1016\/j.cej.2025.161200. 509,161200.","journal-title":"Chem Eng J"},{"key":"3440_CR45","doi-asserted-by":"publisher","first-page":"214170","DOI":"10.1016\/j.ccr.2021.214170","volume":"448","author":"W Yang","year":"2021","unstructured":"Yang W, Yang X, Zhu L, Chu H, Li X, Xu W. Nanozymes: activity origin, catalytic mechanism, and biological application. Coordin Chem Rev. 2021;448:214170. https:\/\/doi.org\/10.1016\/j.ccr.2021.214170.","journal-title":"Coordin Chem Rev"},{"key":"3440_CR46","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1021\/acs.chemrev.8b00672","volume":"119","author":"Y Huang","year":"2019","unstructured":"Huang Y, Ren J, Qu X. Nanozymes: classification, catalytic mechanisms, activity regulation, and applications. Chem Rev. 2019;119:4357\u2013412. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00672.","journal-title":"Chem Rev"},{"key":"3440_CR47","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.bioactmat.2022.07.016","volume":"25","author":"S Zeng","year":"2023","unstructured":"Zeng S, Chen C, Zhang L, Liu X, Qian M, Cui H, Wang J, Chen Q, Peng X. Activation of pyroptosis by specific organelle-targeting photodynamic therapy to amplify Immunogenic cell death for anti-tumor immunotherapy. Bioact Mater. 2023;25:580\u201393. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.07.016.","journal-title":"Bioact Mater"},{"key":"3440_CR48","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1038\/s41467.019.11269.8","volume":"10","author":"W Li","year":"2019","unstructured":"Li W, Yang J, Luo L, Jiang M, Qin B, Yin H, Zhu C, Yuan X, Zhang J, Luo Z. Targeting photodynamic and photothermal therapy to the Endoplasmic reticulum enhances Immunogenic cancer cell death. Nat Commun. 2019;10:3349. https:\/\/doi.org\/10.1038\/s41467.019.11269.8.","journal-title":"Nat Commun"},{"key":"3440_CR49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7150\/thno.67300","volume":"12","author":"B Ji","year":"2022","unstructured":"Ji B, Wei M, Yang B. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Theranostics. 2022;12:434. https:\/\/doi.org\/10.7150\/thno.67300.","journal-title":"Theranostics"},{"key":"3440_CR50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.actbio.2021.11.009","volume":"138","author":"H Yu","year":"2022","unstructured":"Yu H, Li Y, Zhang Z, Ren J, Zhang L, Xu Z, Kang Y, Xue P. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy. Acta Biomater. 2022;138:545\u201360. https:\/\/doi.org\/10.1016\/j.actbio.2021.11.009.","journal-title":"Acta Biomater"},{"key":"3440_CR51","doi-asserted-by":"publisher","first-page":"20400","DOI":"10.1021\/acsnano.2c06646","volume":"16","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Dong S, Liu Y, Wang J, Ba L, Zhang C, Cao X, Wu C, Yang P. Tumor microenvironment-activable manganese-boosted catalytic immunotherapy combined with PD-1 checkpoint Blockade. ACS Nano. 2022;16:20400\u201318. https:\/\/doi.org\/10.1021\/acsnano.2c06646.","journal-title":"ACS Nano"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03440-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03440-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03440-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:13:40Z","timestamp":1749082420000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03440-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3440"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03440-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee of Hangzhou Medical College (Number: HZMCS23020323).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have read and approved this version of the article for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"417"}}